Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
July 14, 2015
Patent Application Number
14229736
Date Filed
March 28, 2014
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present disclosure provides TC-83 VEE-derived replicons, alphaviral replicon particles and immunogenic compositions containing TC-83 alphaviral replicon particles which direct the expression of at least one antigen when introduced into a suitable host cell. The TC-83 VEE-derived ARPs described herein are improved in that they are subject to a lower vector-specific immune response than prior art ARPs.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
